It is now well established that many mammalian species possess leukocytes that are able to lyse a variety of tumors in vitro without prior immunization (1, 2) . These cells have been termed natural killer (NK) t cells . Characterization of the NK cells reactive against different lymphoid and solid tumor targets has revealed that they share certain properties but differ in others . For example, NK activity of spleen cells against the lymphoma YAC-1 is very low in mice injected with the bone-seeking isotope 89 Sr and in mice <3 wk of age (3) . In contrast, NK activity against EL-4 lymphoma cells is relatively unaffected in mice treated with 89Sr and is present in mice 5 d old (4) . However, both the NK (YAC-1) and NK (EL-4) activities are stimulated by interferon inducers administered in vivo (4) . Stutman and coworkers (5, 6) have characterized an NK cell active against solid tumors that they have termed a natural cytotoxic (NC) cell. One notable difference between NC cells and the typical NK cell active against lymphoid tumors is that NC cells remain functional after incubation at 37°C for as long as 6 d, whereas NK cells are labile at 37°C for as few as 6 h under the same culture conditions (5, 6) . These results suggest that NK cells in general may be a heterogenous population . For purposes of discussion, we will designate all non-T, non-B, and non-macrophage cells active in the natural cytotoxicity assay as NK cells and will propose a tentative classification of NK cells .
To evaluate the concept of heterogeneity of NK cells, we have used a variety of methods to distinguish between NK cells reactive against a panel of tumors, both lymphoid and nonlymphoid . Our studies, presented here, indicate that NK cells in fresh spleen cell suspensions can be classified into two broad categories on the basis of their susceptibility to suppression by treatment with 89 Sr, presence of NK alloantigens, and activity in beige (bg/bg) mice.
Materials and Methods
Mice.
(C57BL/6 X DBA/2)F1 (B6D2F1), B10.D2, CBA/J, C57BL/6J, C57BL/6J-bg/bg, and BALB/c mice were purchased from either The Jackson Laboratory (Bar Harbor, Maine) or Charles River Breeding Laboratories (Wilmington, Mass.) . Neonatal mice were obtained Cr, experimental -sponta neous (medium) mean percent cytotoxicity = , cpm X 100. maximal (H20) -spontaneous
The variation between the replicates was <5%. Spontaneous release values depended on the tumor target and the assay time but did not exceed one-third of the maximum release value in the experiments reported herein. Where single figures are given, they are taken from the corresponding linear part of the E:T vs . percent cytotoxicity curve.
Cold competition experiments were performed as described in detail previously (4, 11) by using E:T ratios of 50 :1 for YAC-1 and 25 :1 for WEHI-164 .1 and adding varying numbers of cold (i .e ., unlabeled) targets, generally at cold to hot (e1 Cr-labeled) cell ratios (C :H) of 50 :1, 25 : 1, and 12 .5 :1 . Note that C:H ratios of 50 :1 were not exceeded because nonspecific inhibition, particularly with tumor cells, becomes significant at high C :H ratios (11) . 51Cr release values with labeled and cold targets were never significantly different from spontaneous release values with labeled targets alone.
Mouse Pretreatments. Heat-killed Corynebacterium parvum organisms (Wellcome Laboratories, Raleigh, N. C.) were injected intraperitoneally (2 .1 mg/mouse) . Cyclophosphamide was obtained from Mead Johnson and Co ., Evansville, Ind.; mice were injected intraperitoneally with 300 mg/kg body weight . 6-8-wk-old mice were injected with 100 110 89 Sr (Oak Ridge National Laboratory, Oak Ridge, Tenn .) intraperitoneally and used 4-6 wk after the injection. Mice were irradiated in a small-animal irradiator (Gammacell 40, Atomic Energy of Canada Ltd., Commercial Products, Ottawa, Ontario, Canada ; dual 137Cs sources, 136 rad/min) . The details of these procedures have been described earlier (4) .
Cell Pretreatments . Treatment of spleen cells with CE anti-CBA, anti-Nk-1 .2, serum (9, 10) and pretested rabbit complement (C) was performed by the following protocol . Erythrocytes were removed from a fresh spleen cell suspension by hypotonic shock and 20 X 106 lymphocytes from this suspension were treated with a 1 :40 dilution of anti-Nk-1 .2 for 30 min at 37°C in complete RPMI-1640 without fetal calf serum. The cells were washed once in complete RPMI-1640 and treated with C (1 :8 dilution) for 30 min at 37°C in serum-free medium. The cells were washed once and then adjusted to the appropriate concentration for an NK cell assay. The viability of spleen cells after treatment with anti-Nk-1 .2 plus C was 95-97%.
Results
NK Activity of Spleen Cells from 89Sr-treated Mice. NK activity against YAC-1, C1 .18, and MPC-11 was markedly reduced in B6D2F1 and 1110 .132 mice pretreated with the bone-seeking isotope 89 Sr (Table I ) . In contrast, NK reactivity against FLD-3 and WEHI-164 .1 was not different from spleen cells obtained from 89 Sr-treated 1110 .132 mice as compared with untreated controls . When spleen cells from 89Sr-treated B6D2F1 mice were used as effectors, NK activity against WEHI-164 .1 was modestly reduced and, in some cases, NK (FLD-3) activity was greatly reduced .
To ascertain whether the reduced NK (FLD-3) activity seen in some B6D2F1 mice was due to lack of functional NK effector cells, as is the case with NK (YAC-1) (7), or due to the presence of suppressor cells, a cell mixture experiment was performed (Fig .  1) . The NK (FLD-3) activity of normal spleen cells could be greatly reduced by the addition of spleen cells from 89Sr-treated mice. This finding is in accord with our previous observations relating to NK (EL-4) cells . NK (EL-4), like NK (FLD-3), is usually normal in 89 Sr-treated mice, but when reduced, the lowering can be accounted for by the presence of suppressor cells (4, 12) . On the other hand, NK (YAC-1) is always lowered in 89 Sr-treated mice, and similar cell mixture experiments have consistently failed to demonstrate suppressor cells in our hands (4, 12) .
Effect of Anti-M-1.2 plus C on NK Activity. The NK activity in fresh spleen cells from BALB/c mice against YAC-1 and C1 .18 was markedly reduced by prior treatment of the spleen cells with anti-Nk-1 .2 plus C (Table II) . In contrast, NK activity against FLD-3 and WEHI-164 .1 was largely resistant to treatment with anti- Nk antibody plus C. It should be noted however, that in some experiments with antiNk-1 .2 plus C, a twofold reduction in NK activity against WEHI-164.1 has been observed. However, this must be compared with the total abolition of NK activity against YAC-1, which is generally effected by this treatment (Table II) . NK Activity in Beige Mice . C57BL/6 mice homozygous for the beige mutation (bg/bg) have reduced NK activity against YAC-1 lymphoma cells in short-term 5'Cr release assays (13) . In contrast, NK activity against FLD-3 and WEHI-164.1 is normal in such mice (Table III) . The low NK (YAC-1) seen in beige mice can be partially and in some experiments totally corrected by a prolongation of the assay period to 16 h (Table III) , which suggests that any defect in NK activity against FLD-3 and BALB/c C 25 WEHI-164 .1 can be masked by the longer duration of the assay. If this were so, no distinction could be made between NK (YAC-1) and NK or NK (WEHI-164 .1) on the basis of data from beige mice. That this is not the case was clarified when we tested the ability of anti-Nk-1 .2 plus C-treated spleen cells of beige mice to lyse YAC-1 cells in a long-term assay . Table III shows that although some Nk (YAC-1) reactivity can be seen in beige spleen cells, when the effectors and targets are incubated for 16 h, all such activity is mediated by Nk-1 .2 antigen-positive cells, whereas the NK reactivity against WEHI-164 .1 in beige mice is, as expected, mediated by cells not sensitive to anti-Nk-1 .2 plus C treatment .
NK Activity of Spleen Cellsfrom Mice Pretreated with C. parvum or Cyclophosphamide. The NK activity against FLD-3 and WEHI-164 .1 was enhanced by pretreatment with C. parvum similar to the increase seen with YAGI (Table IV) . Pretreatment with cyclophosphamide, an agent known to suppress NK activity, reduced NK activity in B6D2F1 mice against FLD-3 and YAC-1 . The cytotoxic activity against WEHI-164.1, however, was generally found to be resistant to the suppressive effect of cyclophosphamide. Pretreatment with cyclophosphamide reduces the number of nucleated cells obtained from a spleen by 60-75% (unpublished observations) . Therefore, cyclophosphamide reduced the total number of NK cells in the spleen against all targets, but it further decreased the frequency of NK cells active against FLD-3 and YAC-1 . In contrast, the frequency of NK cells reactive against WEHI-164 .1 was not affected . Effect of Lethal Irradiation on NK Activity in B6D2F1 Mice . We were interested in testing the effect of short-term lethal irradiation on NK activity against FLD-3 and WEHI-164 .1 because the YAC-1 NK cell has already been shown to be radio resistant (3) . B6D2F1 mice were lethally irradiated (800 rad) and 3 d later, their pooled spleen cells had retained NK activity against YAC-1 and WEHI-164 .1 but had lost the ability to lyse FLD-3 ( Table V) . As with cyclophosphamide, short-term lethal irradiation reduced the total number of nucleated cells in the spleen by 80-90% . Therefore, the frequency of NK cells active against YAC-1 and WEHI-164.1 was normal but that against FLD-3 was decreased .
Effect of Age on NK Activity. As with YAC-1 (1, 2), the NK activity in B6 mice <3 wk old against FLD-3 was reduced when compared with B6 adult mice (Table VI) . In contrast, spleen cells from (B6 X C3H)F l mice 1 d old were able to lyse WEHI-164 .1 as well as adult mice. There was no lytic activity against YAC-1 cells in 1-d-old (B6 X C3H)F t mice.
Competitive Inhibition of NK Activity against YAC-1 and WEHI-164.1. To test whether the antigens recognized by NK cells against different targets were similar, we carried out cold competition studies (Table VII) . These results indicate that the NK cell that kills YAC-1 recognizes target structures that are expressed on YAC-1 and C1 .18, whereas the NK cell that lyses WEHI-164 .1 is largely specific for that target . There was some inhibition of YAC-1 lysis by FLD-3 and WEHI-164 .1, suggesting either However, the fact that some reduction of NK activity against WEHI-164.1 can often be achieved by treatment of spleen cells with anti-Nk-1 .2 plus C (Table II and our unpublished observations) suggests that WEHI-164.1 might be susceptible to lysis by two different NK cell types : the major activity is WEHI-164.1 specific, preserved in neonatal, beige, and a9Sr-treated mice, and is resistant to anti-Nk-1 .2 plus C treatment, and a minor component is mediated by the NK cell that lyses YAC-1, which recognizes a separate shared target structure on the two tumors . the beige mutation, and the susceptibility to lysis by an anti-Nk-1 .2 alloantiserum and complement . Our earlier studies had indicated that NK activity against YAC-1 but not EL-4 lymphoma was reduced in 89Sr-treated mice (4, 12) . An analysis of low NK (YAC-1) activity in 89Sr-treated mice has indicated that an intact bone marrow microenvironment may be essential for the full functional differentiation of NK (YAC-1) cells (7) . By this criterion, NK cells could be classified into those that are marrow dependent, such as NK cells reactive against YAC-1, RL d-1, MPC-11, and 01.18, whereas those reactive against FLD-3,2 EL-4, and WEHI-164.1 can differentiate from splenic stem cells in the absence of an intact bone marrow . The NC cell activity against BALB/c methylcholanthrene (meth A)-induced sarcoma is also minimally affected in e9Sr-treated mice (19) . It is interesting to note that this notion of marrow dependence is also supported by studies in estrogen-treated mice. Mice treated with high doses of estrogens develop osteopetrosis, and these mice are strikingly similar to 89Sr-treated mice with respect to NK activity (20, 21) . NK (YAC-1) activity is reduced, it is not boosted significantly by an interferon inducer (pI :pC), and yet NK (or NC) activity against the BALB/c meth A sarcoma is unaffected (19) . Preliminary results obtained in osteopetrotic humans (lacking normal bone marrow) also show a lowered NK reactivity against HSV-1-infected fibroblasts (C. Lopez, personal communication), supporting the concept of marrow dependence of certain human NK cells . It should be pointed out that although NK reactivity against EL-4 and FLD-3 is often normal in most 89Sr-treated mice, it is low in some instances . However, the reduction in activity against these targets in 89Sr-treated mice is generally triggered by the "activation" of suppressor cells by interferon inducers (12) and not due to a lack of functional NK cells.
The experiments with anti-Nk-1 .2 alloantiserum provide independent evidence for the subclassification ofNK cell activity into two classes . The antiserum used has been defined in detail elsewhere (9, 10) . Under the conditions used here, this serum is NK cell specific and stains only 2-5% of spleen cells (22; unpublished observations in a fluorescence-activated cell sorter analysis) . It seems more than coincidental that marrow-dependent NK cells, i.e,, those that lyse YAC-1, 01 .18, and MPC-11, are also Nk-1 .2 antigen positive, as defined by significant reduction in NK activity by pretreatment with anti-Nk-1 .2 plus C. The marrow-independent NK cells, including those that lyse meth A sarcoma (O. Stutman, personal communication), are resistant to such a treatment and may, by this criteria, be considered Nk-1 .2 antigen negative . We cannot state with certainty that NK (FLD-3) and NK (WEHI-164.1) are totally devoid of Nk-1 .2 antigens. The possibilities of very low antigen density and resistance to complement-mediated lysis must also be considered . It may be recalled that Ly-5 antigen is expressed on several cell types, including T cells, NK cells, and B cells. However, B cells cannot be lysed by anti-Ly-5 serum plus C under the usual conditions (23) . Although resistance to C-mediated lysis cannot be ruled out completely, it seems to be an unlikely explanation because NK (WEHI-164 .1) can be lysed by heterologous anti-mouse and anti H-2 antisera and C.3 Nevertheless, positive selection studies will be required to answer this question definitively .
Studies in beige mice further support and extend the notion ofNK cell heterogeneity developed from the aforementioned experiments . The function of the Nk antigenpositive, marrow-dependent class of NK cells is impaired in beige mice (Table III) . However, the lytic ability of beige spleen cells can be considerably restored by prolongation of the NK assay (Table III) . Thus, the beige mutation appears to cause more of a delay in, rather than lack of, killing. Cells that mediate such delayed killing of targets of the YAC-1 type are still distinguishable from those that are responsible for the lysis of WEHI-164.1 cells, which normally take longer to be lysed, by being susceptible to anti-Nk-1 .2 plus C . It is interesting to note that beige mice and 89Sr-treated mice seem to have defects affecting the same class of cells, and there are some similarities between beige mice and 89 Sr-treated mice. These include a relative resistance to boosting by interferon and a normal frequency of target-binding cells (7, 13) . Nevertheless, the basis of the NK defect in 89Sr-treated and beige mice must be quite different, because beige mice seem to have a stem cell defect (13) . Thus their "NK defect" can be adoptively transferred to normal mice by bone marrow cells, and they themselves can be largely "cured" by normal hemopoietic stem cell transplants . On the other hand, the low NK (YAC-1) of 89Sr-treated mice cannot be cured by a normal bone marrow cell infusion, and spleens of 89Sr-treated mice do possess normal stem cells for NK (YAC-1) (7, 24) .
One difference between the two categories ofNK cells is the length oftime required for target cell lysis. In general targets such as YAC-1, RL d'-1, and MPG-11, can be lysed in a shorter period of time (4-6 h), whereas tumors such as WEHI-164.1, FLD-3, and meth A take a longer period of incubation for optimal lysis (12-48 h) . Could the differences be related merely to the length of the assay? We do not believe this to be the case because spleen cells from Sr treatment . That this is not the case is indicated by our preliminary studies (25) , in which equivalent amounts of interferon were generated in 24-h culture supernates of spleen cells with a variety of tumor cells, including YAC-1, FLD-3, and some NK-insensitive tumor cells such as L1210, but no correlation was found between the induction of interferon in vitro and the lysis of the tumor cell line.
On the basis of the data discussed above, we propose that NK cells be classified into two categories : NK-A cells would include the Nk antigen-positive, marrowdependent NK cells, and NK-B would designate Nk antigen-negative cells, which have normal activity in 89Sr-treated and beige mice (Table VIII) . The NC cells described by Stutman et al. (5) would thus fall into the NK-B category . It appears that NK-A cells that react largely against lymphoid targets are a much more homogenous group as compared with NK-B cells (Table VIII) . NK-B cells all share certain common characteristics, but also differ from each other in several respects. For example, although NK cells reactive against the meth A sarcoma (19) , WEHI-164.1, and FLD-3 are all marrow independent and Nk antigen negative, NK (FLD-3) differ Further investigations may reveal subsets among the two major categories we have defined . At present, however, similarities between the cells classified as NK-B seem significant enough to group them together. This distinction between NK-A and NK-B can be applied solely to the NK activity of normal fresh spleen cells, because boosting with interferon or in vitro culture is known to change the physical characteristics, antigen expression, and target selectivity of NK-like cells (26, 27) . It is tempting to speculate that the NK-B cells that are Nk antigen negative and marrow independent may be precursors of NK-A cells ; the transition from NK-B to NK-A may require an intact marrow . In previously reported experiments (4), we have found that NK (EL-4) appears earlier than NK (YAC-1) in the spleens of lethally irradiated mice transplanted with normal syngeneic precursor bone marrow cells . However, such a schema is by no means proven, and delineation of the relationships between NK-A and NK-B cells must await further investigations . In closing, it may be pointed out that the existence of two or more classes of NK cells does not necessarily argue for or against heterogeneity of putative NK cell receptors or their clonal distribution . T and B cells, which are two distinct classes of immunocompetent cells, are known to share similar idiotypic determinants (28) . It is therefore conceivable that distinct classes of cells that can mediate natural cytotoxicity may use similar recognition structures if common cell surface antigens are present on their target cells .
Summary
Mice were treated with the bone-seeking isotope, 89 Sr, cyclophosphamide, and short-term lethal irradiation in vivo, and murine spleen cells were treated with antiNk-1 .2 plus complement (C) in vitro. Fresh spleen cell suspensions from the above groups and from beige and neonatal mice were subsequently tested for natural killer (NK) cell activity against a panel of lymphoid and nonlymphoid tumor cell targets. NK cell reactivities against YAC-1, MPC-11, and C1.18 tumors were markedly and consistently reduced in (a) mice treated with 89Sr, (b) spleen cells treated with antiNk-1 .2 plus C, and (c) C57BL/6 bg/bg mice. In contrast, NK activities against FLD-3 and WEHI-164.1 tumors were usually normal in mice treated with 89 Sr, in beige mutant mice, and in spleen cells after treatment with anti-Nk-1 .2 antibody and C. It appears, therefore, that two major groups of NK cells exist in fresh mouse spleen cell suspensions . NK-A cells are marrow dependent, Nk antigen positive, and deficient in beige mice; these lyse YAC-1, MPC-11, and C1.18 tumors. NK-B cells, which are responsible for the lysis of WEHI-164.1 and FLD-3, are Nk antigen negative, marrow independent, and unaffected by the bg{bg mutation . Other features of NK-B cells suggest that these NK cells, although they share the characteristics mentioned above, differ among themselves especially with respect to age ofmaturation and susceptibility to cyclophosphamide and total body irradiation . The NK-B group may therefore include subsets that remain to be defined .
